Belgium· BE-AMP-SAM660755-00
Amvuttra 25 mg
A vutrisiran product containing vutrisiran sodium, registered in Belgium by Alnylam Netherlands. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Vutrisiran is registered in 14 of 19 countries.
Countries holding a registration under ATC N07XX18 (vutrisiran), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Vutrisiran · ATC N07XX18
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vutrisiran costs, country by country.
Normalised to the WHO defined daily dose (0.278 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vutrisiran · price per daily dose (0.278 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1135.51
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Vutrisiran Sodium
- Manufacturer
- Alnylam Netherlands
- Country
- Belgium (BE)
- ATC code
- N07XX18
- ATC class
- Vutrisiran
- Defined daily dose
- 0.278 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4776035
- be_apb7739428
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vutrisiran in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4041aa70-011e-4049-9c0b-94dcb0216c65 GET /v1/drugs/4041aa70-011e-4049-9c0b-94dcb0216c65?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Amvuttra 25 mg",
"name_fr": "Amvuttra 25 mg",
"name_nl": "Amvuttra 25 mg",
"amp_code": "SAM660755-00",
"strengths": [
"25.0000",
"25.0000"
],
"pack_count": 1,
"substances": [
"Vutrisiran Sodium",
"Vutrisiran",
"Disodium Hydrogen Phosphate Dihydrate",
"Sodium Dihydrogen Phosphate Dihydrate",
"Sodium Chloride",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Vutrisiran",
"authorisation_numbers": [
"EU/1/22/1681/001"
]
}See everything about vutrisiran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.